BC
EIGR

Broadfin Capital’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Broadfin Capital’s Portfolio EIGR Stock Details EIGR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$18.4M Sell
2019
Q3 		$14M Sell
2019
Q2 		$17.6M Buy
2019
Q1 		$2.7M Buy
2018
Q4 		$1.46M Buy